Overview
Kosuke Fujino practices in Chuo, Japan. Mr. Fujino is rated as an Experienced expert by MediFind in the treatment of Pulmonary Fibrosis. His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Endoscopy.
His clinical research consists of co-authoring 49 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Pulmonary Fibrosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung CancerMr. Fujino isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaMr. Fujino isAdvanced. Learn about Lung Adenocarcinoma.
- Lung CancerMr. Fujino isAdvanced. Learn about Lung Cancer.
- Small Cell Lung Cancer (SCLC)Mr. Fujino isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- Acute Interstitial PneumoniaMr. Fujino isExperienced. Learn about Acute Interstitial Pneumonia.
- EndoscopyMr. Fujino isExperienced. Learn about Endoscopy.
- Heart TumorMr. Fujino isExperienced. Learn about Heart Tumor.
- Idiopathic Pulmonary FibrosisMr. Fujino isExperienced. Learn about Idiopathic Pulmonary Fibrosis.
- Interstitial Lung DiseaseMr. Fujino isExperienced. Learn about Interstitial Lung Disease.
- Lung NodulesMr. Fujino isExperienced. Learn about Lung Nodules.